This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignees: Green Cross Labcell, Mogam Biotechnology Institute. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: Bokyung Min: Innovator in Natural Killer Cell Production
Introduction
Bokyung Min is a notable inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of biotechnology, particularly in the production of natural killer (NK) cells. His innovative methods have the potential to enhance therapeutic approaches for treating cancers and infectious diseases.
Latest Patents
Bokyung Min holds a patent titled "Method for producing natural killer cells, natural killer cells produced thereby, and composition for treating cancers and infectious diseases containing the same." This invention provides a method for producing NK cells that maintain high cytotoxicity and cell viability. The method allows for ex vivo culture at high efficiency and concentration, ensuring optimal conditions for the cells. Notably, the NK cells can be stored and supplied in liquid or frozen states without requiring additional treatment processes.
Career Highlights
Throughout his career, Bokyung Min has worked with reputable organizations such as Mogam Biotechnology Institute and Green Cross Labcell. His experience in these institutions has contributed to his expertise in cell production and biotechnology.
Collaborations
Bokyung Min has collaborated with several professionals in his field, including Hana Choi and Eun-Kyoung Lee. These collaborations have likely enriched his research and development efforts in the production of NK cells.
Conclusion
Bokyung Min's innovative work in the production of natural killer cells represents a significant advancement in biotechnology. His contributions have the potential to improve treatment options for various diseases, showcasing the importance of innovation in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile